Adv Sci (Weinh) May 2023 PMID 36815385

Immunogenic Cell Death in Hematological Malignancy Therapy.

Zhaoyun Liu, Xintong Xu, Kaining Liu, Jingtian Zhang, Dan Ding, Rong Fu

Full text PDF Download social card

Mentions

Peak: 1 in Feb 2023

across 2 sources since Feb 2023

Extended reach

493

potential audience

Total likes

Video views

Mentions per month

Feb 2023 – Feb 2024

Where it's discussed

X / Twitter2 posts
YouTube1 videos

AI synopsis

What people are saying

The group of discussions frequently references the potential of ICD to activate the immune system against blood cancers, with phrases like 'promising immunotherapy approach' and 'combining with other treatments.' Words such as 'innovative,' 'exciting,' and 'hopeful' reflect a positive and engaged attitude toward the article's content, pointing to its perceived significance in advancing hematological malignancy therapy.

AgreementModerate agreement

Most posts agree that immunogenic cell death is a promising area for advancing blood cancer therapies.

InterestHigh interest

Discussions show high curiosity and enthusiasm, with many posts highlighting the potential to improve treatments.

EngagementModerate engagement

Comments include references to mechanisms, ongoing research, and clinical implications, indicating thoughtful engagement.

ImpactModerate impact

While some emphasize the transformative potential of ICD, others view it as an emerging promising approach rather than a fully established breakthrough.

Abstract in brief

Hematological malignancies' treatments have improved, but issues like relapse and drug resistance remain, often influenced by the disorder in the tumor microenvironment.
Immunogenic cell death (ICD) is a special type of regulated cell death that can activate the immune system by releasing danger signals called DAMPs, offering a promising immunotherapy approach.
The review discusses how inducing ICD can be combined with other treatments to improve outcomes for patients with blood cancers, highlighting ongoing research in this area.]

Read the full abstract

All mentions

Immunogenic Cell Death as a Promising Immunotherapy for Blood Cancers

Hematological malignancies' treatments have improved, but issues like relapse and drug resistance remain. The review discusses how inducing immunogenic cell death can activate the immune system and improve treatment…

STEM RTCL TV · Aug 21, 2023 30 views

Hematology Frontier

@Hematology_F · X

Immunogenic Cell Death in Hematological Malignancy Therapy https://t.co/sfVaiDNjks

Feb 20, 2024 · 60 followers View post →

Karoyan Philippe

@KaroyanPhilippe · X

Immunogenic Cell Death in Hematological Malignancy Therapy https://t.co/3TV8cQHtDP

Feb 25, 2023 · 1 like · 403 followers View post →